Skip to main content
. 2021 Sep 7;26:e933313-1–e933313-7. doi: 10.12659/AOT.933313

Table 2.

Viremic parameter of donor and recipient before and after transplantation.

Recipient Donor Paired recipient



HCV RNA IU/mL HCV Ab Genotype HCV RNA IU/mL
Week 12 ot * Week 12 fu # Week 4 ot * Week 2 ot * 3a 583 1



0 0 0 0.37/0.11 1b 369000 2



0 0 0 0.04/0.2 2a 727000 3



0 0 0 0.06/0.04 1b 168000 4



0 0 0 2.07/1.68 3b 147000 5



0 0 0 1.72/1.29 3a 654000 6

0 0 0 0.11



0 0 0 0.02 2a 342000 7



0 0 0 0.08/0.09 3b 113000 8



0 0 0 0.05 1b 217000 9



0 0 0 0.04/0.07 3a 668000 10



0 0 0 0.42 2a 438000 11



0 0 0 0.09/0.08 3a 935000 12



0 0 0 0.03/0.07 3b 477000 13



0 0 0 0.2/0.08 1b 537000 14



0 0 0 0.08/0.05 3b 1100000 15
*

ot – on treatment of antiviral therapy;

#

fu – follow-up after antiviral treatment.